Freedom Capital lowered the firm’s price target on Aehr Test Systems (AEHR) to $23 from $24 and keeps a Hold rating on the shares. The company’s fiscal Q2 results missed estimates due to the impact of shipment delays and unfavorable mix, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AEHR: